DAX23.168 -0,6%Est505.693 -0,7%MSCI World4.343 -0,1%Top 10 Crypto8,7000 -0,6%Nas21.879 +0,2%Bitcoin58.252 +0,3%Euro1,1514 ±0,0%Öl109,2 +9,0%Gold4.676 -1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 NVIDIA 918422 SAP 716460 Deutsche Telekom 555750 Siemens Energy ENER6Y Microsoft 870747 Allianz 840400 Novo Nordisk A3EU6F BASF BASF11 Tesla A1CX3T Mercedes-Benz Group (ex Daimler) 710000 Nike 866993 Infineon 623100 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach Trumps Iran-Rede: DAX geht leichter ins lange Wochenende -- Wall Street letztlich uneins -- Rheinmetall, Telekom, Intel, Tesla, Öl-Aktien, Micron, Pharmawerte, Airbus, Thales, OHB im Fokus
Top News
Consorsbank-Depot zu teuer? Mit diesem Broker sparst du dauerhaft Gebühren Consorsbank-Depot zu teuer? Mit diesem Broker sparst du dauerhaft Gebühren
Handle bei finanzen.net ZERO auch am Wochenende - jeden Samstag ab 14 Uhr Handle bei finanzen.net ZERO auch am Wochenende - jeden Samstag ab 14 Uhr
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Elanco Animal Health Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
20,00 EUR -0,02 EUR -0,09 %
BMN
19,64 EUR -0,52 EUR -2,59 %
HAML
finanzen.net zero
Elanco Animal Health jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.9,97 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6BH

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS28414H1032

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolELAN

Elanco Animal Health Aktien News

DatumMeistgelesen
PR NewswireELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireELAN Class Action News: Robbins LLP Reminds Investors of the Quickly Approaching Lead Plaintiff Deadline in the Elanco Animal Health Incorporated Class Action
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireElanco to Participate in the Upcoming Investor Conferences
PR NewswireThe Gross Law Firm Notifies Shareholders of Elanco Animal Health Incorporated(ELAN) of a Class Action Lawsuit and an Upcoming Deadline
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireElanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit
PR NewswireElanco Strengthens Board of Directors with Addition of Stacey Ma
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireElanco Animal Health Reports Third Quarter 2024 Results
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireLevi & Korsinsky Reminds Elanco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024 - ELAN
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit
PR NewswireELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireELAN INVESTOR ALERT: Edelson Lechtzin LLP Urges Elanco Animal Health Incorporated (NYSE: ELAN) Shareholders with Substantial Losses to Consult Legal Counsel About the Pending Securities Fraud Clas...
PR NewswireELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireElanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming Deadlines - ELAN
PR NewswireElanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose
PR NewswireElanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
PR NewswireElanco Provides Update on Contract Manufacturing Partner
PR NewswireElanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireElanco Announces Credelio Quattro Moves to Final FDA Administrative Review
PR NewswireCredelio® (lotilaner) Kills Ticks 2x as Fast as Simparica TRIO® (sarolaner, moxidectin and pyrantel) and NexGard® (afoxolaner)
PR NewswireElanco Animal Health Reports Second Quarter 2024 Results
PR NewswireElanco Releases 2023 Environmental, Social and Governance Report, Delivering Healthier Outcomes for Animals, People, Planet and Enterprise
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN
PR NewswireElanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement
PR NewswireElanco Completes Sale of Aqua Business
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN

Elanco Animal Health News

Elanco Animal Health News: auf dieser Seite finden Sie alle Elanco Animal Health News und Nachrichten zur Elanco Animal Health Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Elanco Animal Health News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Elanco Animal Health News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.